Administrative Hearing of a Medical Center for Improper Treatment of a Transgender Person

PINK filed a complaint with the Ministry of Health about the conduct of the medical professionals, after a victim of hate crime in Yerevan (LGBT Activists Targeted in Hate Crime, then Mocked by Hospital Staff) admitted themselves to the N1 hospital in Yerevan, and faced discrimination, being told by medical professionals, “Come, let’s do a blood test on you. Let’s see if you have a deviance”.

An administrative proceeding has been filed with the health inspection department of the Ministry of Health against irreverent treatment and improper medical service provided by the personnel of the “First medical center ‘Heratsi’”. The personnel of the medical center conducted themselves unprofessionally and treated the patient seeking treatment with disrespect, which was related to the appearance and gender identity of the victim. During the administrative hearing, the representatives of the health inspection department rejected the fact that the personnel of medical center had behaved inappropriately, clarifying that the definition of irreverent and improper treatment is not determined by sub legislative acts. They justified the behavior of the medical personnel, saying that the blood analysis is obligatory for everyone who has been beaten.

The personnel of the medical center declared that they have watched the video of security cameras and that there was no such treatment on the part of the medical center’s personnel. But after a motion to examine the video during the hearing and to attach it to the case materials, they answered that the video had been self-deleted.

On March 25 Ministry of Health informed that the case is suspended due to the absence of violation.

FDA approves first drug to prevent HIV infection

Dr. Lisa Sterman holds up a Truvada pill at her office in San Francisco in May. Even before the Food and Drug Administration's approval, Sterman had prescribed Truvada for about a dozen patients at high risk for developing AIDS. Photo by Jeff Chiu/AP

The Food and Drug Administration has given the first OK for a drug to prevent HIV infection.

The daily pill Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's been a mainstay in the treatment of HIV/AIDS for years, and as of today is an approved option for reducing the risk of HIV infection for people at high risk.

The drug was approved for people who test negative for HIV infection. It's supposed to be used in combination with safe-sex practices, such as using a condom, to reduce infection risk. "Truvada alone shouldn't be used to prevent HIV infection," FDA's Dr. Debra Birnkrant, said in a media briefing.

People taking Truvada should be tested for HIV infection every three months, so treatment can begin promptly if an infection has occurred.

An outside panel of experts had recommend the agency take the action after concluding that the benefits to healthy people vulnerable to HIV infection outweigh the risks, including such side effects as kidney damage and a dangerous increase in acid in the blood.

About 50,000 people in the U.S. become infected with HIV each year, according to the Centers for Disease Control and Prevention. The majority of new infections are in gay or bisexual men.

Birnkrant said the steady rate of new infections showed that more options are needed to reduce transmission of the virus. "Truvada for pre-exposure prevention represents another effective evidence-based approach," she said.

But the cost for prevention isn't trivial. The annual tab for Truvada ranges from about $11,000 to $14,000.

In an interview with Talk of Nation's Neal Conan in May, the National Institute of Health's Anthony Fauci, said of Truvada, that it's "an important component of the broad tool kits that we do have for prevention."

He acknowledged the risks, such as side effects, and the possibility that some people taking the drug might engage in riskier behavior because they think they're protected.

In response to a question about that from NPR's Richard Knox today, FDA's Birnkrant said studies of Truvada for prevention found an increase in condom use over time — not a drop. (Listen to Knox's story on Monday's All Things Considered for more.)

During the Fauci interview conducted shortly after the expert panel recommended FDA approval of Truvada for prevention, he said, "I agree with the advisory committee strongly that when you balance the benefits of this, making this available, to the risks, ... the benefits far outweigh the risks, although you must take seriously the potential downsides of it and be prudent in your use of this."

source: NPR

Make it happen! The Vienna YouthForce pre-conference

On July 14 the Vienna YouthForce begins its three-day pre-conference, an event open to young people attending the 18th International AIDS Conference. The pre-conference conists of informative sessions and skills-building workshops on HIV and AIDS issues ranging from scientific knowledge to effective political advocacy.

The pre-conference brings together more than 300 young activists and researchers from 100 different countries to prepare youth delegates to be effective advocates on issues that affect them. All the activities are organized in partnership with other activists and organizations who voluntarily participate on various different committees.

Public Information and Need of Knowledge Armenian NGO is presented by Marine Margaryan, NGO's projects coordinator.

Every two years, tens of thousands of experts, advocates and decision-makers gather for the international AIDS conference, the largest health-related event in the world. With each conference, young people, who have so much at stake in addressing this issue, have been playing an increasingly large role in the proceedings.

The overall theme for the conference is Rights Here! Right Now. The advocacy campaign of the Vienna YouthForce focuses on the 3 HRs: human rights, harm reduction and health resources.

TB/HIV, universal access, and human rights key items

The Executive Director of UNAIDS, Mr Michel Sidibé, was in Brazil promoting greater awareness of the interlinked epidemics of HIV and tuberculosis, the need for universal access to HIV services for all people in need, and the necessity to address stigma and discrimination in Brazils response to HIV.

On March 24, 2009 in Rio de Janeiro, Mr Sidibé joined the international launch of the World Health Organizations (WHO) annual report on global TB control.

Although it is mostly preventable and curable, tuberculosis (TB) is one of the leading causes of death among people living with HIV globally. Of the 33 million people who are living with HIV, only 20% of know their status, and only a tiny fraction, 2% in 2007, were screened for TB according to the Global TB Control 2009 report.

"We have to stop people living with HIV from dying of tuberculosis. Universal access to HIV prevention, treatment, care and support must include TB prevention, diagnosis and treatment. When HIV and TB services are combined, they save lives," said Mr Sidibé.

source: UN News Centre

Capacity Building for Armenia’s health sector

This August, in collaboration with the Yerevan Women’s Resource Center, Lory Hovsepian (Ph.D. candidate in Public Health, Université de Montréal) and Apraham Niziblian (Lobbying and advocacy specialist) will facilitate a three-day conference, supported by the Canadian International Development Agency (CIDA) entitled: Capacity Building for Armenia’s health sector. This project will focus on developing community capacity in Armenia’s health sector, specifically regarding the promotion of sexual/reproductive health and the prevention of HIV/sexually transmitted infections in Armenia. Community organizations working in Armenia on these issues have been invited, with the hopes of knowledge transfer and capacity building, culminating in the creation of a collaborative effort to maximize effective promotion of key sexual health issues within the Armenian public.
In recent years, our experience with various civil society groups working in the Armenian health and social sectors has suggested that although there are many community organizations working either in the realm of sexual health or with vulnerable groups, these organizations often work independently and collaborative efforts on common projects are rare. Moreover, prior fieldwork and needs analysis have indicated need for common spaces where these organizations can come together, share experiences and expertise, learn from each other, all in a collaborative spirit. This situation has led us to believe that there is a need to create such a space and to facilitate concerted action in the area of sexual health. This common space will allow for needs analysis and knowledge transfer, following which it is our hope that the organizations present will pursue the steps, and that the process will culminate into the possible creation of a form of partnership – whether it be in the form of a consortium, coalition, or ‘table de concentration’ (the outcome, of course, will be left to the actors/stakeholders involved, reflecting their needs/interests in such collaborative efforts). Such collaborative efforts can only be beneficial to the attainment of the objectives set forth in the realm of sexual health in Armenia.

Invitation
Given our belief that it is through concerted, intersectoral and multi-level action that change can be brought forth, such a process cannot be successful without the inclusion and implication of all representatives of the health sector, including representatives of academic, health and governmental institutions. In this respect, we invite "PINK" NGO to participate in this conference. It is through the collaborative effort of organizations such as "PINK Armenia" that we can create the needed concerted effort in the Armenian health sector. In an effort to be as inclusive as possible, we would like to request your help in reaching out to other organizations that may be interested in participating in this conference.
The conference will consist of three half-day workshop sessions between August 12 and 15, 2008. The August 15 session will be followed by a networking event. During this event, representatives from various groups and institutions (e.g. Ministry of Health, health sector practitioners and researchers) will be invited to discuss possible venues of collaboration in the short and long term.